Suppr超能文献

CD11c(+)单核细胞/巨噬细胞通过产生白细胞介素-23促进肝螺杆菌诱导的慢性肠道炎症。

CD11c(+) monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23.

作者信息

Arnold I C, Mathisen S, Schulthess J, Danne C, Hegazy A N, Powrie F

机构信息

Translational Gastroenterology Unit, Experimental Medicine Division-NDM, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

出版信息

Mucosal Immunol. 2016 Mar;9(2):352-63. doi: 10.1038/mi.2015.65. Epub 2015 Aug 5.

Abstract

In inflammatory bowel diseases, a breakdown in host microbial interactions accompanies sustained activation of immune cells in the gut. Functional studies suggest a key role for interleukin-23 (IL-23) in orchestrating intestinal inflammation. IL-23 can be produced by various mononuclear phagocytes (MNPs) following acute microbial stimulation, but little is known about the key cellular sources of IL-23 that drive chronic intestinal inflammation. Here we have addressed this question using a physiological model of bacteria-driven colitis. By combining conditional gene ablation and gene expression profiling, we found that IL-23 production by CD11c(+) MNPs was essential to trigger intestinal immunopathology and identified MHCII(+) monocytes and macrophages as the major source of IL-23. Expression of IL-23 by monocytes was acquired during their differentiation in the intestine and correlated with the expression of major histocompatibility complex class II (MHCII) and CD64. In contrast, Batf3-dependent CD103(+) CD11b(-) dendritic cells were dispensable for bacteria-induced colitis in this model. These studies reinforce the pathogenic role of monocytes in dysregulated responses to intestinal bacteria and identify production of IL-23 as a key component of this response. Further understanding of the functional sources of IL-23 in diverse forms of intestinal inflammation may lead to novel therapeutic strategies aimed at interrupting IL-23-driven immune pathology.

摘要

在炎症性肠病中,宿主与微生物相互作用的破坏伴随着肠道免疫细胞的持续激活。功能研究表明,白细胞介素-23(IL-23)在肠道炎症的调控中起关键作用。急性微生物刺激后,多种单核吞噬细胞(MNP)可产生IL-23,但对于驱动慢性肠道炎症的IL-23的关键细胞来源知之甚少。在此,我们使用细菌驱动的结肠炎生理模型解决了这个问题。通过结合条件性基因敲除和基因表达谱分析,我们发现CD11c(+)MNP产生IL-23对于触发肠道免疫病理学至关重要,并确定MHCII(+)单核细胞和巨噬细胞是IL-23的主要来源。单核细胞在肠道分化过程中获得了IL-23的表达,且与主要组织相容性复合体II类(MHCII)和CD64的表达相关。相比之下,在该模型中,Batf3依赖性的CD103(+)CD11b(-)树突状细胞对于细菌诱导的结肠炎并非必需。这些研究强化了单核细胞在对肠道细菌的失调反应中的致病作用,并确定IL-23的产生是该反应的关键组成部分。进一步了解不同形式肠道炎症中IL-23的功能来源,可能会带来旨在中断IL-23驱动的免疫病理学的新治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验